Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only
- 1 August 2001
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 121 (2) , 500-501
- https://doi.org/10.1053/gast.2001.26927
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapyGastroenterology, 2000
- Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemiaLeukemia, 2000
- Pharmacogenomics: The promise of personalized medicineAAPS PharmSci, 2000
- Pharmacogenomics: Translating Functional Genomics into Rational TherapeuticsScience, 1999
- METHYLATION PHARMACOGENETICS: Catechol O-Methyltransferase, Thiopurine Methyltransferase, and Histamine N-MethyltransferaseAnnual Review of Pharmacology and Toxicology, 1999
- Thiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from AzathioprineAnnals of Internal Medicine, 1998
- Thiopurine S -methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrateEuropean Journal of Clinical Pharmacology, 1998
- Azathioprine: State of the Art in Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1998
- Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*Clinical Pharmacology & Therapeutics, 1997
- Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphismClinical Pharmacology & Therapeutics, 1989